Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9542 |
High Similarity |
NPD2796 |
Approved |
0.913 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9037 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9037 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8971 |
High Similarity |
NPD1549 |
Phase 2 |
0.8921 |
High Similarity |
NPD6799 |
Approved |
0.8889 |
High Similarity |
NPD1510 |
Phase 2 |
0.8872 |
High Similarity |
NPD1240 |
Approved |
0.8857 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8741 |
High Similarity |
NPD1607 |
Approved |
0.8652 |
High Similarity |
NPD1511 |
Approved |
0.863 |
High Similarity |
NPD2801 |
Approved |
0.8621 |
High Similarity |
NPD7411 |
Suspended |
0.8613 |
High Similarity |
NPD3748 |
Approved |
0.8582 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD3817 |
Phase 2 |
0.8562 |
High Similarity |
NPD6801 |
Discontinued |
0.8552 |
High Similarity |
NPD6599 |
Discontinued |
0.8531 |
High Similarity |
NPD1512 |
Approved |
0.8503 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD7819 |
Suspended |
0.85 |
High Similarity |
NPD1243 |
Approved |
0.8446 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8435 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8433 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8425 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8345 |
Intermediate Similarity |
NPD920 |
Approved |
0.8345 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8333 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8333 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8298 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8239 |
Intermediate Similarity |
NPD2654 |
Approved |
0.8239 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8207 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8074 |
Intermediate Similarity |
NPD3266 |
Approved |
0.8074 |
Intermediate Similarity |
NPD3267 |
Approved |
0.8026 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8013 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7986 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7985 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7961 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7958 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7941 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7935 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7931 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7922 |
Intermediate Similarity |
NPD919 |
Approved |
0.7914 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7914 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7875 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7872 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7852 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7832 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7812 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.781 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7801 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7737 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7687 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7677 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7655 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7654 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7643 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7635 |
Intermediate Similarity |
NPD2309 |
Approved |
0.763 |
Intermediate Similarity |
NPD17 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD2532 |
Approved |
0.76 |
Intermediate Similarity |
NPD2534 |
Approved |
0.76 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7552 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7552 |
Intermediate Similarity |
NPD943 |
Approved |
0.7552 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7535 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD3226 |
Approved |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7453 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7424 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7379 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7379 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7372 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7353 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7326 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD411 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7256 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7241 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7125 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7103 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD5242 |
Approved |
0.707 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7051 |
Intermediate Similarity |
NPD5586 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7023 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7021 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7021 |
Intermediate Similarity |
NPD1201 |
Approved |
0.702 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7
|
Intermediate Similarity |
NPD9261 |
Approved |